Marinus Pharmaceuticals(MRNS) - 2024 Q1 - Quarterly Results

Exhibit 99.1 Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results RADNOR, Pa. – May 8, 2024 – Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today reported business highlights and financial results for the first quarter ended March 31, 2024. "Our unwavering commitment is to develop innovative treatment options for individuals with seizure disorders," said S ...